Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
20,250,000
-
Total 13F shares
-
1,812,147
-
Share change
-
+152,824
-
Total reported value
-
$8,498,422
-
Price per share
-
$4.68
-
Number of holders
-
18
-
Value change
-
+$709,549
-
Number of buys
-
8
-
Number of sells
-
7
Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) as of Q1 2023
As of 31 Mar 2023 enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) had 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,812,147 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, KINGDON CAPITAL MANAGEMENT, L.L.C., UBS OCONNOR LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, and ARTHUR M. COHEN & ASSOCIATES, LLC.
This table shows 18 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.